This implies that passive immunization with tau antibodies can be a viable therapeutic focus on and that the CSF volume of p-tau262/356 or in the microtubule binding domain (MTBD) can function a practical biomarker of tau pathology to watch tau therapeutics in clinical trials.Immerse you in TAU’s bold and emotionally billed works, wherever cubist… Read More